Current Assets
Inventories
Vertex Pharmaceuticals Inventories increased by 4.7% to $1.77B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 29.9%, from $1.36B to $1.77B. Over 5 years (FY 2020 to FY 2025), Inventories shows an upward trend with a 43.1% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026
How to read this metric
Increasing inventory may signal anticipated demand growth or supply chain stockpiling, whereas excessive growth relative to sales could indicate obsolescence risk.
Detailed definition
This includes the value of raw materials, work-in-progress, and finished pharmaceutical products held by the company. It...
Peer comparison
Biotech companies often carry significant inventory to ensure consistent supply of life-saving medications.
Metric ID:
inventoriesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $321.62M | $333.46M | $353.1M | $338.9M | $367.7M | $388.2M | $460.6M | $535.1M | $603.5M | $688.7M | $738.8M | $813.1M | $914.6M | $1.08B | $1.21B | $1.36B | $1.5B | $1.63B | $1.69B | $1.77B |
| QoQ Change | — | +3.7% | +5.9% | -4.0% | +8.5% | +5.6% | +18.7% | +16.2% | +12.8% | +14.1% | +7.3% | +10.1% | +12.5% | +18.1% | +11.6% | +12.8% | +10.3% | +8.5% | +3.7% | +4.7% |
| YoY Change | — | — | — | — | +14.3% | +16.4% | +30.4% | +57.9% | +64.1% | +77.4% | +60.4% | +52.0% | +51.5% | +56.8% | +63.2% | +67.2% | +63.9% | +50.7% | +39.9% | +29.9% |
Range$321.62M – $1.77B
CAGR+43.1%
Avg YoY Growth+49.8%
Median YoY Growth+54.4%
Current Streak16 quarters growth
Inventories at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's inventories?
- Vertex Pharmaceuticals (VRTX) reported inventories of $1.77B in Q1 2026.
- How has Vertex Pharmaceuticals's inventories changed year-over-year?
- Vertex Pharmaceuticals's inventories increased by 29.9% year-over-year, from $1.36B to $1.77B.
- What is the long-term trend for Vertex Pharmaceuticals's inventories?
- Over 5 years (2020 to 2025), Vertex Pharmaceuticals's inventories has grown at a 43.1% compound annual growth rate (CAGR), from $280.8M to $1.69B.
- What does inventories mean?
- The total value of all raw materials and finished drug products held in stock.